482 results on '"Pao W"'
Search Results
2. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
3. Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers
4. Flow Profile Distribution in Narrow Annuli Using Modified Yield Power-Law Fluid Model
5. Drilling Parameter Effects on Cuttings Transport in Horizontal Wellbores: A Review
6. Development of an Intelligent Passive Device Generator for Road Vehicle Applications.
7. Paradigms for the development of transformative medicines—lessons from the EGFR story
8. From academia to industry: a road more travelled
9. Desynapsis in the Common Wheat
10. IA04 Early-Stage Drug Development in the 21st Century
11. Experimental investigation of two-phase separation in a horizontal T-junction with vertical branch arm
12. P1.01-25 Real-World Outcomes of Advanced NSCLC Patients with Common and Uncommon/Complex EGFR Mutation Profiles
13. Serum Levels of Surfactant Protein D Are Increased in Mice With Lung Tumors*
14. Distribution of, and immune response to, chicken anti-αGal immunoglobulin Y antibodies in wild-type and αGal knockout mice
15. Experimental investigation of multiphase separation in different flow regimes through T-junction with an expander section
16. Numerical validation of gas-liquid slug flow inside horizontal pipe
17. VISUALIZATION AND MORPHOLOGICAL CHARACTERIZATION OF INTEGRAL SKIN CELLULAR POLYMERIC COMPOSITES USING X-RAY MICROTOMOGRAPHY
18. Numerical investigation on the effect of balcony open and solid upstand on smoke contamination in atrium balconies
19. Numerical simulation of two-phase slug flow with liquid carryover in different diameter ratio T-junction
20. Numerical simulation of two-phase separation in a small diameter ratio T-junction
21. Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far
22. Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia
23. Numerical analyses for improved hydrodynamics of deep water torpedo anchor
24. Desynapsis and other abnormalities induced by high temperature
25. Cuttings-liquid frictional pressure loss model for horizontal narrow annular flow with rotating drillpipe
26. Capillary pressure and buoyancy effects in the CO2/brine flow system
27. 250 Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes
28. Continued Afatinib (A) With the Addition of Cetuximab (C) After Progression on Afatinib in Patients With Acquired Resistance (AR) to Gefitinib (G) or Erlotinib (E)
29. 86O - Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far
30. Pre-Clinical and Clinical Evaluation of Azd9291, a Mutation-Specific Inhibitor, in Treatment-Naïve Egfr Mutated Nsclc
31. Targeting Resistance in Egfr-Mutant Non-Small Cell Lung Cancer (Nsclc): Preclinical Evidence Supporting the Combination of Egfr Tyrosine Kinase Inhibitors (Tkis) Azd9291 and Gefitinib with Molecularly Targeted Agents and Immunotherapeutics
32. Increased cortical arousal propensity in opiate users with complex sleep apnea syndrome
33. t(5;6)(q33-34;q23) CEP85L/PDGFRB
34. Constant interference methods for power allocation in orthogonal frequency division multiplexing-based cognitive radio networks
35. Activity of Afatinib/Cetuximab in Patients (PTS) with EGFR Mutant Non-Small Cell Lung Cancer (Nsclc) and Acquired Resistance (Ar) To EGFR Inhibitors
36. Application of next generation sequencing to human gene fusion detection: computational tools, features and perspectives
37. Nomogramme prédictif des mutations activatrices de l’EGFR dans les adénocarcinomes pulmonaires
38. 9018 POSTER DISCUSSION Identification of Driver Mutations in Tumour Specimens From 1000 Patients With Lung Adenocarcinoma for the Lung Cancer Mutation Consortium (LCMC)
39. "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
40. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies
41. Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
42. Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC).
43. My Cancer Genome: Web-based clinical decision support for genome-directed lung cancer treatment.
44. DIRECT: DNA-mutation Inventory to Refine and Enhance Cancer Treatment—A catalogue of clinically relevant somatic mutations in lung cancer.
45. Characterization of novel potent and selective anaplastic lymphoma kinase (ALK) inhibitors.
46. A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC).
47. Activity and tolerability of afatinib (BIBW 2992) and cetuximab in NSCLC patients with acquired resistance to erlotinib or gefitinib.
48. Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI).
49. Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib.
50. Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.